| Product NDC: | 66794-012 |
| Proprietary Name: | Sojourn |
| Non Proprietary Name: | Sevoflurane |
| Active Ingredient(s): | 99.9 mL/100mL & nbsp; Sevoflurane |
| Administration Route(s): | NASAL |
| Dosage Form(s): | INHALANT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66794-012 |
| Labeler Name: | Piramal Critical Care Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077867 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100413 |
| Package NDC: | 66794-012-25 |
| Package Description: | 250 mL in 1 BOTTLE, GLASS (66794-012-25) |
| NDC Code | 66794-012-25 |
| Proprietary Name | Sojourn |
| Package Description | 250 mL in 1 BOTTLE, GLASS (66794-012-25) |
| Product NDC | 66794-012 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sevoflurane |
| Dosage Form Name | INHALANT |
| Route Name | NASAL |
| Start Marketing Date | 20100413 |
| Marketing Category Name | ANDA |
| Labeler Name | Piramal Critical Care Inc |
| Substance Name | SEVOFLURANE |
| Strength Number | 99.9 |
| Strength Unit | mL/100mL |
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |